SkyOak Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
SkyOak Wealth's BMY Position: Q1 2026 in Review
SkyOak Wealth held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 4,171 shares worth $253K. The position accounts for 0.05% of the portfolio, ranked #204.
SkyOak Wealth first reported a position in BMY in Q4 2019 and has held it in 20 quarters since. The position peaked at $387K in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- SkyOak Wealth held 4,171 shares of Bristol-Myers Squibb worth $253K as of Q1 2026.
- SkyOak Wealth left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.05% of SkyOak Wealth's portfolio in Q1 2026, its #204 holding.
- SkyOak Wealth first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 20 quarters since.
- SkyOak Wealth's Bristol-Myers Squibb position peaked at $387K in Q1 2023.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on SkyOak Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.